Priscilla N. Kelly
- Cell Biology top 1%
- Hematology top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 9
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 4
- Genetics top 2%
- Molecular Biology top 2%
- Cell death mechanisms and regulation 11
- Gut microbiota and health 6
-
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
-
- Clostridium difficile and Clostridium perfringens research 4
- Co-authors
- Andreas StrasserJerry M. AdamsStephen L. NuttAleksandar DakicHamsa PuthalakathEwa M. MichalakPhilippe BouilletDavid C.S. Huang
- Cited by
- Cell BiologyHematologyOncology
- Journals
- Science (72 papers)Cell (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Priscilla N. Kelly
84 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Cell Biology 915
- Hematology 618
- Oncology 1.3k
- Genetics 394
- Molecular Biology 2.5k
Countries citing papers authored by Priscilla N. Kelly
This map shows the geographic impact of Priscilla N. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla N. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla N. Kelly more than expected).
Fields of papers citing papers by Priscilla N. Kelly
This network shows the impact of papers produced by Priscilla N. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla N. Kelly. The network helps show where Priscilla N. Kelly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Priscilla N. Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 0 | |
| 5 | 2020 | 0 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 0 | |
| 9 | 2018 | 2 | |
| 10 | 2017 | 2 | |
| 11 | 2016 | 18 | |
| 12 | 2011 | 15 | |
| 13 | 2011 | 368 | |
| 14 | 2009 | 70 | |
| 15 | 2008 | 51 | |
| 16 | 2008 | 23 | |
| 17 | Programmed Anuclear Cell Death Delimits Platelet Life Spanbreakdown → | 2007 | 767 |
| 18 | ER Stress Triggers Apoptosis by Activating BH3-Only Protein Bimbreakdown → | 2007 | 1159 |
| 19 | 2007 | 15 | |
| 20 | 1987 | 46 |
About Priscilla N. Kelly
Priscilla N. Kelly is a scholar working on Immunology, Biological Psychiatry and Oncology, having authored 92 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Cancer-related Molecular Pathways (9 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), Gut microbiota and health (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). The work is most often cited by research in Cell Biology (915 citations), Hematology (618 citations) and Oncology (1.3k citations). Priscilla N. Kelly has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Andreas Strasser, Jerry M. Adams, Stephen L. Nutt, Aleksandar Dakic, Hamsa Puthalakath, Ewa M. Michalak, Philippe Bouillet, David C.S. Huang, Lorraine A. O’Reilly and Andrew W. Roberts. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.